SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

Report of Foreign Issuer


Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month of May 2012

 

Commission File Number 000-20181

 

Sapiens International Corporation N.V.
(translation of registrant’s name into English)

 

c/o Landhuis Joonchi

Kaya Richard J. Beaujon z/n
P.O. Box 837

Willemstad,
Curaçao
(599) (9) 7366277
(address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F S    Form 40-F £

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): £

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): £

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934

Yes £   No S

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.

 

 

 

 

 

 

Sapiens Q1 2012 Revenue nearly doubled year over year reaching $26 Million

  

Non-GAAP Net Income Grows 63% to $3.2 Million;

 

REHOVOT, Israel, May 8, 2012 -- Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces its financial results for the first quarter ended March 31, 2012.

 

First Quarter 2012 Highlights Include:

Commenting on the first quarter results, Roni Al Dor, President and CEO of Sapiens International, "The first quarter was a good start for Sapiens, as we begin our first full year following the acquisitions of IDIT and FIS. Our revenue grew by 95%, non-GAAP net income & non-GAPP operating profit both increased 63.0%. We will continue to improve the operational efficiencies of the newly acquired entities and expand the margins, as we have done many times in the past, with other companies, including Sapiens itself.

 

As a global provider of insurance solutions, with new products, geographical coverage and channels to sell in to, we are very encouraged about our opportunities for growth. We are seeing high demand for our products in North America, and have increased our staff by 30 employees in the last quarter due to demand from customers. Compounding our growth prospects are the market dynamics, insurance companies shifting its information technology (IT) spend to external providers.”

 

Mr. Al Dor continued, “We reiterate our guidance for 2012 to grow revenue in excess of $100 million.”

 

Reconciliation between U.S. GAAP and Non-GAAP results is summarized in the following table. For a complete reconciliation, please refer to the tables at the end of this release.

 

-2-
 

 

(U.S. Dollars in thousands, except per share amounts)

 

   For the three months ended
U.S GAAP basis  3/31/2012  3/31/2011
   (Unaudited)  (Unaudited)
Revenues   25,983    13,325 
Operating profit   2,441    1,720 
Net income attributable to Sapiens   2,388    1,673 
Basic earnings per share   0.06    0.08 
Diluted earnings per share   0.06    0.07 
           
Non-GAAP          
Revenues   25,983    13,325 
Operating profit   3,308    2,034 
Net income attributable to Sapiens   3,211    1,963 
Basic earnings per share   0.08    0.09 
Diluted earnings per share   0.08    0.08 

 

First Quarter 2012 Results

 

Revenue for the first quarter of 2012 was $26.0 million, compared to $13.3 million for the first quarter of 2011; an increase of 95%. Net income attributable to Sapiens on a GAAP basis was $2.4 million for the first quarter of 2012, compared to net income of $1.7 million for the first quarter of 2011. EPS was $0.06 per diluted share for the first quarter of 2012 compared to $0.07 per diluted share for the first quarter of 2011. GAAP operating income was $2.4 million for the first quarter of 2012, compared to $1.7 million for the first quarter of 2011.

 

Non-GAAP net income attributable to Sapiens for the first quarter of 2012 totaled $3.2 million, compared to non-GAAP net income of $2.0 million for the first quarter of 2011. Non-GAAP EPS was $0.08 per diluted share for the first quarter of 2012, compared to $0.08 per diluted share for the first quarter of 2011. Non-GAAP operating income was $3.3 million for the three months ended March 31, 2012, compared to $2.0 million in the same period last year.

 

About Sapiens International

 

Sapiens International Corporation (NASDAQ and TASE: SPNS), is a leading global provider of innovative business solutions for the insurance industry, helping to modernize business processes, to proactively define and provide innovative new services and to respond quickly to changes in the industry. We offer end to end solutions for the L&P, P&C and Reinsurance markets, with customers across the globe. We jointly serve over 70 insurance customers, backed by a team of over 700 insurance experts. Coupled with our financial stability, Sapiens aims to become the vendor of choice in the insurance software marketplace. For more information about Sapiens, visit http://www.sapiens.com.

 

 

Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of accounting policies, specific system configurations and software needs of individual customers and other risk factors.

 

Investor Relations Contact: 
Roni Giladi, CFO 
Sapiens International 
Tel: +972-8-9382721 
E-mail:
roni.g@sapiens.com

or

James Carbonara, Regional Vice President

Hayden IR

Office: (646)-755-7412

James@haydenir.com

 

 

-3-
 

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Balance Sheets
(U.S. Dollars in thousands)
         

 

   3/31/2012  12/31/2011
   (Unaudited)  (Audited)
Assets          
           
Cash and cash equivalents  $27,093   $21,460 
Restricted cash  464    456 
Trade receivables, net   18,953    14,484 
Other current assets   3,476    3,229 
Total current assets   49,986    39,629 
           
           
Property and equipment, net   1,767    1,814 
Other assets, net   113,740    112,025 
           
Total assets  $165,493   $153,468 
           
           
Liabilities and shareholders' equity          
           
           
Trade payables  $2,530   $2,559 
Other liabilities and accrued expenses   18,019    19,731 
Deferred revenue   17,271    9,603 
Total current liabilities   37,820    31,893 
           
Long-term debt and other long-term liabilities   11,591    11,328 
Equity   116,082    110,247 
           
Total liabilities and equity  $165,493   $153,468 

 

-4-
 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V.
Condensed Consolidated Statements of Operations
(U.S. Dollars in thousands, except per share amounts)
         

 

   For the three months ended
   3/31/2012  3/31/2011
    Unaudited    Unaudited 
           
Revenues  $25,983   $13,325 
           
Cost of revenues  $15,157   $7,125 
           
Gross Profit   10,826    6,200 
           
Operating expenses          
Research and development, net  $2,300   $1,060 
Selling, marketing, general and administrative  $6,085   $3,420 
           
Operating Profit   2,441    1,720 
           
Financial expenses (income), net  $(61)  $41 
Other expenses, net  $108   $6 
           
Net Income  $2,393   $1,673 
           
Attributetable to non-controlling interest  $5   $—   
           
Net income attributable to Sapiens  $2,388   $1,673 
           
Earnings per share          
Basic  $0.06   $0.08 
Diluted  $0.06   $0.07 
           
Weighted average number of shares used to computation of earnings per share          
      
Basic   39,719    21,602 
Diluted   42,401    23,199 

 

 

-5-
 

 

 

  SAPIENS INTERNATIONAL CORPORATION N.V.
  Reconciliation  of GAAP to Non-GAAP results
  (U.S. Dollars in thousands, except per share amounts)
             

 

   For the three months ended
   3/31/2012  3/31/2011
   (Unaudited)  (Unaudited)
GAAP operating profit   2,441    1,720 
Amortization of intangibles assets and compensation related to acquisition   863    294 
Amortization of capitalized software   834    1,090 
Capitalization of software development   (980)   (1,155)
Stock-based compensation   150    85 
           
Total adjustments to GAAP   867    314 
Non-GAAP operating profit   3,308    2,034 
           
GAAP net income   2,388    1,673 
Total adjustments to GAAP as above   867    314 
Non-controlling interest in amortization intangible assets   (24)   —   
Deferred taxes related to acquisition   (20)   (24)
Non-GAAP net income   3,211    1,963 
           
Non-GAAP basic earnings per share   0.08    0.09 
           
Non-GAAP diluted earnings  per share   0.08    0.08 
           
Weighted average number of shares used to computation of earnings per share          
Basic   39,719    21,602 
           
Diluted   42,401    23,199 

 

 

 

 

-6-
 

  

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Sapiens International Corporation N.V.
  (Registrant)
     
     
Date: May 8, 2012 By: /s/ Roni Giladi
    Roni Giladi
    Chief Financial Officer

 

 

-7-